Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $544,000.

  • Rockwell Medical's Depreciation & Amortization (CF) rose 0.18% to $544,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.2 million for FY2024, which is 50.97% up from last year.
  • As of Q3 2025, Rockwell Medical's Depreciation & Amortization (CF) stood at $544,000, which was down 3.37% from $563,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) registered a high of $564,000 during Q3 2023, and its lowest value of $133,000 during Q4 2021.
  • In the last 3 years, Rockwell Medical's Depreciation & Amortization (CF) had a median value of $544,000 in 2025 and averaged $479,091.
  • As far as peak fluctuations go, Rockwell Medical's Depreciation & Amortization (CF) crashed by 39.55% in 2021, and later spiked by 294.41% in 2023.
  • Over the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) (Quarterly) stood at $133,000 in 2021, then grew by 15.79% to $154,000 in 2022, then spiked by 257.14% to $550,000 in 2023, then decreased by 1.27% to $543,000 in 2024, then rose by 0.18% to $544,000 in 2025.
  • Its Depreciation & Amortization (CF) was $544,000 in Q3 2025, compared to $563,000 in Q2 2025 and $539,000 in Q1 2025.